Business · 05/08/1999

FDA Announces Public Meeting to Discuss Proposed Rule on Postapproval Drug Changes

The FDA is hosting a public meeting to gather feedback on proposed changes to its regulations on postapproval changes to approved drugs and a draft companion guidance, inviting industry, healthcare professionals, patients, and advocacy groups to share their perspectives.